CH478143A - Procédé pour la préparation de nouveaux esters polynicotiniques - Google Patents

Procédé pour la préparation de nouveaux esters polynicotiniques

Info

Publication number
CH478143A
CH478143A CH644668A CH644668A CH478143A CH 478143 A CH478143 A CH 478143A CH 644668 A CH644668 A CH 644668A CH 644668 A CH644668 A CH 644668A CH 478143 A CH478143 A CH 478143A
Authority
CH
Switzerland
Prior art keywords
polynicotinic
esters
preparation
new
polynicotinic esters
Prior art date
Application number
CH644668A
Other languages
English (en)
Inventor
L Leroi Eugene
Original Assignee
Soc D Etudes Prod Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Etudes Prod Chimique filed Critical Soc D Etudes Prod Chimique
Publication of CH478143A publication Critical patent/CH478143A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • C07D311/28Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only
    • C07D311/30Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3 with aromatic rings attached in position 2 only not hydrogenated in the hetero ring, e.g. flavones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/06Benzopyran radicals
    • C07H17/065Benzo[b]pyrans
    • C07H17/07Benzo[b]pyran-4-ones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH644668A 1967-05-23 1968-04-30 Procédé pour la préparation de nouveaux esters polynicotiniques CH478143A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21078/67A GB1179019A (en) 1967-05-23 1967-05-23 Polynicotinic Esters of Flavonoids

Publications (1)

Publication Number Publication Date
CH478143A true CH478143A (fr) 1969-09-15

Family

ID=10156835

Family Applications (1)

Application Number Title Priority Date Filing Date
CH644668A CH478143A (fr) 1967-05-23 1968-04-30 Procédé pour la préparation de nouveaux esters polynicotiniques

Country Status (7)

Country Link
US (1) US3751570A (fr)
BE (1) BE714423A (fr)
CH (1) CH478143A (fr)
ES (1) ES353537A1 (fr)
FR (2) FR1561764A (fr)
GB (1) GB1179019A (fr)
NL (1) NL132132C (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602778A5 (fr) * 1975-05-16 1978-07-31 Hommel Ag
GB1575004A (en) * 1976-03-23 1980-09-17 Iverni Della Beffa Spa Pharmacologically active polyphenolic substances
IT1232343B (it) * 1989-09-28 1992-01-28 Eurogefi S P A Derivati idrosolubili di bioflavonoidi di glicosidici, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
EP0863746A1 (fr) * 1996-09-18 1998-09-16 Marigen S.A. Peresters de glycoside de bioflavonol et leur preparation en concentres et ultramicroemulsions a action pharmacologique
KR100213895B1 (ko) * 1996-10-14 1999-08-02 박원훈 감귤류 과피 추출물, 이로부터 분리 정제된 헤스페리딘 또는 나린진을 포함하는 심혈관 질환 예방및 치료제 조성물
AUPR255401A0 (en) * 2001-01-16 2001-02-08 Novogen Research Pty Ltd Regulation of lipids and/or bone density and compositions therefor
WO2006045010A2 (fr) 2004-10-20 2006-04-27 Resverlogix Corp. Stilbenes et chalcones utilises pour la prevention et le traitement de maladies cardio-vasculaires
AU2006275514B2 (en) 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
CA2676984C (fr) 2007-02-01 2015-03-17 Resverlogix Corp. Composes destines a la prevention et au traitement de maladies cardiovasculaires
US8114995B2 (en) 2008-06-26 2012-02-14 Resverlogix Corp. Methods of preparing quinazolinone derivatives
ES2542835T3 (es) 2009-01-08 2015-08-12 Resverlogix Corporation Compuestos para la prevención y el tratamiento de enfermedades cardiovasculares
JP5795304B2 (ja) 2009-03-18 2015-10-14 レスバーロジックス コーポレイション 新規抗炎症剤
KR101892987B1 (ko) 2009-04-22 2018-08-30 리스버로직스 코퍼레이션 신규한 소염제
CA2851996C (fr) 2011-11-01 2020-01-07 Resverlogix Corp. Compositions pharmaceutiques pour des quinazolinones substituees
WO2014080290A2 (fr) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Amines cycliques servant d'inhibiteurs de bromodomaines
WO2014080291A2 (fr) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Dérivés biaryle servant d'inhibiteurs de bromodomaines
EP2935253B1 (fr) 2012-12-21 2018-08-01 Zenith Epigenetics Ltd. Nouveaux composés hétérocycliques en tant qu'inhibiteurs de bromodomaine
CA2977308A1 (fr) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions et procedes therapeutiques pour le traitement de maladies associees au complement

Also Published As

Publication number Publication date
FR7941M (fr) 1970-05-25
GB1179019A (en) 1970-01-28
ES353537A1 (es) 1969-10-01
US3751570A (en) 1973-08-07
NL132132C (fr) 1971-03-15
NL6806337A (fr) 1968-11-06
FR1561764A (fr) 1969-03-28
DE1770324B2 (de) 1976-07-22
BE714423A (fr) 1968-09-16
DE1770324A1 (de) 1972-04-20

Similar Documents

Publication Publication Date Title
CH478143A (fr) Procédé pour la préparation de nouveaux esters polynicotiniques
FR1508526A (fr) Procédé pour la préparation de maléimides
CH481115A (fr) Procédé pour la préparation de nouvelles cinnamylpipérazines
FR1533763A (fr) Procédé pour la préparation de thio-semicarbazides
CH485769A (fr) Procédé de préparation d'esters de la diméthylsulfamoyl-3 hydroxyéthyl pipéridinopropyl-10 phénothiazine
CH485720A (fr) Procédé de préparation de 4-aryl-4-aminoalkoxy-pipéridines
FR1547627A (fr) Procédé de préparation d'esters n-carbamoyloxyphényl-carbamiques
CH500230A (fr) Procédé de préparation de nouveaux phosphorothiolates
CH511792A (fr) Procédé pour la préparation de nouveaux esters polyfluorés
FR1515100A (fr) Procédé amélioré pour la préparation de sulfolanes
CH490340A (fr) Procédé de préparation de nouveaux cyclopeptides
CH496702A (fr) Procédé de préparation de 4-anilino-pyridines-N-substituées
CH510600A (fr) Procédé de préparation de nouveaux halogénobenzylphénols
FR1522917A (fr) Procédé pour la préparation de cyclopent-2-énones substituées
CH490086A (fr) Procédé pour la préparation de substances anti-tumeur
CH489514A (fr) Procédé pour la préparation de carboxy-2-thiolanes
CH503760A (fr) Procédé de préparation de pénicillines
FR1509702A (fr) Procédé de préparation de nouveaux oestratriènes
FR1533581A (fr) Procédé de préparation de nouveaux benzènesulfonyl-semicarbazides
FR1475556A (fr) Procédé pour la préparation de fluorphosphates métalliques
CH501605A (fr) Procédé de préparation de nouveaux 3-oxo gonatriènes
CH496681A (fr) Procédé de préparation de nouveaux 3-oxo gonatriènes
CH481137A (fr) Procédé de préparation d'esters furoïques de la Nitro-5 Hydroxy-8 quinoléine
FR1546361A (fr) Procédé pour la préparation d'esters insaturés
FR1509315A (fr) Procédé pour la préparation des stéroïdo-oxazolines

Legal Events

Date Code Title Description
PL Patent ceased